Editor's Comparative Analysis
When choosing between Revista de Homeopatia and Acta Medica Alanya, researchers should consider the trade-off between prestige (Acta Medica Alanya leads with an IF of ) and cost-efficiency, as Revista de Homeopatia is a Diamond Open Access venue.
Revista de Homeopatia is published in BR, while Acta Medica Alanya is headquartered in TR. Both titles are verified via the JournalsHub Live Indexing Tracker for 2026.
| Academic Metric | Revista de Homeopatia | Acta Medica Alanya |
|---|---|---|
| General Information | ||
| Publisher | Associação Paulista de Homeopatia | Alanya Alaaddin Keykubat University |
| Country of Origin | BR | TR |
| Established | 2010 | 2020 |
| Editor-in-Chief | See Website | See Website |
| Scientific Influence | ||
| Current Impact Factor | N/A | N/A |
| Indexing Status |
DOAJ
|
DOAJ
|
| Review Speed (Decision) | Unknown |
104 days
Standard
|
| Acceptance Rate | N/A | N/A |
| Access & Publication Fees | ||
| Open Access Type | Full OA | Full OA |
| APC Fee (Estimated) | FREE (Diamond) | FREE (Diamond) |
Historical Impact Factor Comparison
No historical impact factor data available for these journals yet.
About Revista de Homeopatia
Revista de Homeopatia is a prominent academic journal specializing in Homeopathy and Medicine. Published by Associação Paulista de Homeopatia in BR, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 0102-227X. The journal aims to advance …
View Full ProfileAbout Acta Medica Alanya
Acta Medica Alanya is a prominent academic journal specializing in Medicine. Published by Alanya Alaaddin Keykubat University in TR, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 2587-0319. The journal aims to advance the boundaries …
View Full ProfileSearching for: Revista de Homeopatia impact factor, Acta Medica Alanya APC fees, journal comparison tool 2026.